title: [Which tumor markers should be used in primary bronchial cancers?].
authors.affiliation: Service de Pneumologie, Hôpital St-Antoine, Paris.
authors.forename: M P
authors.initials: MP
authors.lastname: Schuller
authors.forename: F
authors.initials: F
authors.lastname: Carrat
authors.forename: T
authors.initials: T
authors.lastname: Urban
authors.forename: B
authors.initials: B
authors.lastname: Lebeau
mesh_terms: D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen; D002283:Carcinoma, Bronchogenic / Q000175:diagnosis*; D006801:Humans; D053539:Keratin-19; D007633:Keratins; D008175:Lung Neoplasms / Q000175:diagnosis*; D010751:Phosphopyruvate Hydratase; D012680:Sensitivity and Specificity
chemical_list: D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen; D053539:Keratin-19; C102012:antigen CYFRA21.1; D007633:Keratins; D010751:Phosphopyruvate Hydratase